Heska Corp. (HSKA) Reaches New 12-Month High at $52.33
Heska Corp. (NASDAQ:HSKA) reached a new 52-week high on Tuesday . The stock traded as high as $52.33 and last traded at $52.10, with a volume of 69,196 shares traded. The stock had previously closed at $50.35.
Several equities research analysts have recently weighed in on HSKA shares. B. Riley reissued a “buy” rating and set a $52.50 price objective on shares of Heska Corp. in a research note on Saturday. Sidoti started coverage on Heska Corp. in a research note on Friday, July 1st. They set a “buy” rating and a $49.00 price objective for the company. TheStreet raised Heska Corp. from a “hold” rating to a “buy” rating in a research note on Wednesday, May 25th. Zacks Investment Research raised Heska Corp. from a “hold” rating to a “buy” rating and set a $48.00 price objective for the company in a research note on Wednesday, July 13th. Finally, Gabelli lowered Heska Corp. from a “buy” rating to a “hold” rating in a research note on Thursday, August 4th. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus price target of $52.83.
The firm has a market capitalization of $351.96 million and a P/E ratio of 53.26. The stock’s 50 day moving average price is $41.36 and its 200-day moving average price is $35.10.
Heska Corp. (NASDAQ:HSKA) last posted its earnings results on Wednesday, August 3rd. The company reported $0.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.18 by $0.17. The firm earned $30 million during the quarter, compared to the consensus estimate of $28.47 million. The company’s quarterly revenue was up 25.5% compared to the same quarter last year. Equities research analysts expect that Heska Corp. will post $1.03 EPS for the current fiscal year.
In related news, CEO Kevin S. Wilson sold 30,736 shares of the business’s stock in a transaction that occurred on Wednesday, August 3rd. The shares were sold at an average price of $47.34, for a total value of $1,455,042.24. Following the completion of the transaction, the chief executive officer now owns 140,720 shares in the company, valued at approximately $6,661,684.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Kevin S. Wilson sold 20,000 shares of the business’s stock in a transaction that occurred on Thursday, June 2nd. The stock was sold at an average price of $36.74, for a total transaction of $734,800.00. Following the completion of the transaction, the chief executive officer now owns 190,000 shares of the company’s stock, valued at approximately $6,980,600. The disclosure for this sale can be found here.
A hedge fund recently bought a new stake in Heska Corp. stock. Ancora Advisors LLC acquired a new stake in Heska Corp. (NASDAQ:HSKA) during the fourth quarter, according to its most recent filing with the SEC. The institutional investor acquired 101,100 shares of the company’s stock, valued at approximately $1,833,000. Ancora Advisors LLC owned about 1.53% of Heska Corp. as of its most recent filing with the SEC.
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.